Injectable hemostatic adjuncts in trauma: Fibrinogen and the FIinTIC study.

J Trauma Acute Care Surg

From the Department of Traumatology, Orthopedic Surgery and Sports Medicine (M.M.), and Department of Plastic and Reconstructive Surgery (M.Z.), Burn Center, Cologne-Merheim Medical Center (CMMC), and Institute for Research in Operative Medicine (IFOM) (M.M.), University of Witten/Herdecke, Cologne, Germany; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology (C.S., H.S.), AUVA Research Center, Vienna; Department of Anaesthesiology and Intensive Care (C.S., H.S.), AUVA Trauma Hospital Klagenfurt, Klagenfurt; Department of Anaesthesiology and Intensive Care (C.S.), AUVA Trauma Center Salzburg, Salzburg; and University Clinic for General and Surgical Intensive Care (D.F.), Medical University Innsbruck, Innsbruck, Austria.

Published: June 2015

Download full-text PDF

Source
http://dx.doi.org/10.1097/TA.0000000000000632DOI Listing

Publication Analysis

Top Keywords

injectable hemostatic
4
hemostatic adjuncts
4
adjuncts trauma
4
trauma fibrinogen
4
fibrinogen fiintic
4
fiintic study
4
injectable
1
adjuncts
1
trauma
1
fibrinogen
1

Similar Publications

Polyvinyl alcohol/chitosan hydrogel based on deep eutectic solvent for promoting methicillin-resistant Staphylococcus aureus-infected wound healing.

Int J Biol Macromol

January 2025

School of Veterinary Medicine, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, PR China; Joint International Research Laboratory of Agriculture and Agri-Product Safety, the Ministry of Education of China, Yangzhou University, Yangzhou, Jiangsu 225009, PR China. Electronic address:

Bacterial-infected wounds usually lead to slow wound healing due to increased inflammation, especially wounds infected by drug-resistant bacteria, which is a serious challenge in the biomedical field. Traditional antimicrobial strategies such as antibiotics lead to a significant increase in drug-resistant strains and have limited efficacy. Therefore, there is an urgent need to develop multifunctional dressings with excellent antibacterial activity and promotion of wound healing.

View Article and Find Full Text PDF

Bactericidal Hemostatic Sponge: A Point of Care Solution to Combat Traumatic Injury.

Adv Healthc Mater

January 2025

Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bengaluru, Karnataka, 560064, India.

Uncontrollable haemorrhage and associated microbial contamination in the battlefield and civilian injuries pose a tremendous threat to healthcare professionals. Such traumatic wounds often necessitate an effective point-of-care solution to prevent the consequent morbidity owing to blood loss or haemorrhage. However, developing superior hemostatic materials with anti-infective properties remains a challenge.

View Article and Find Full Text PDF

Objective: Endoscopic sphincterotomy (EST), especially when anticoagulants are used, carries a significant risk of delayed bleeding. However, the relationship between the use of antithrombotic agents, including direct oral anticoagulants, and post-EST bleeding remains unclear. This study aimed to identify the risk factors for post-EST delayed bleeding when antithrombotic agents were administered according to the guidelines.

View Article and Find Full Text PDF

Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs.

Blood Adv

January 2025

Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Treatment options for the bleeding disorder von Willebrand disease type 2B (VWD2B) are insufficient and fail to address the negative effects of circulating mutant von Willebrand factor (VWF). The dominant-negative nature of VWD2B makes functionally defective VWF an interesting therapeutic target. Previous in vitro studies have demonstrated the feasibility of allele-selective silencing of mutant VWF using small interfering RNAs (siRNAs) targeting common single nucleotide polymorphisms (SNPs) in the human VWF gene, an approach that can be applied irrespective of the disease-causing VWF mutation.

View Article and Find Full Text PDF

Burns carry a large surface area, varying in shapes and depths, and an elevated risk of infection. Regardless of the underlying etiology, burns pose significant medical challenges and a high mortality rate. Given the limitations of current therapies, tissue-engineering-based treatments for burns are inevitable.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!